Pyrrolidine derivatives useful as bace inhibitors

Details for Australian Patent Application No. 2007256405 (hide)

Owner Novartis AG

Inventors Rogel, Olivier; Rueeger, Heinrich; Simic, Oliver; Rondeau, Jean-Michel; Tintelnot-Blomley, Marina; Sirockin, Finton

Agent Davies Collison Cave

Pub. Number AU-A-2007256405

PCT Pub. Number WO2007/140980

Priority 0611064.7 05.06.06 GB

Filing date 4 June 2007

Wipo publication date 13 December 2007

International Classifications

C07D 215/48 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/47 (2006.01) - Quinolines

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

18 December 2008 PCT application entered the National Phase

  PCT publication WO2007/140980 Priority application(s): WO2007/140980

15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007256413-Method for identifying a person and acquisition device

2007256393-Novel hepatocyte-like cells and hepatoblast-like cells derived from hBS cells